Jayne David R.W. 4
4 · Aurinia Pharmaceuticals Inc. · Filed May 22, 2024
Insider Transaction Report
Form 4
Jayne David R.W.
Director
Transactions
- Sale
Common Stock
2024-05-21$5.74/sh−4,946$28,390→ 44,364 total
Footnotes (1)
- [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023.